Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for GLICLAZIDE

Ingredient

GLICLAZIDE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TEVA-GLICLAZIDE	80MG	TABLET	Actual shortage	2026-01-15	2026-01-15	276239
TEVA-GLICLAZIDE	80MG	TABLET	Resolved	2025-05-22	2025-06-27	258121
TEVA-GLICLAZIDE	80MG	TABLET	Resolved	2025-06-05	2025-06-27	259688
TEVA-GLICLAZIDE	80MG	TABLET	Actual shortage	2026-01-08	2026-01-22	275506

Previous
1
…
7
8
9

Showing 81 to 84 of 84

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
APO-GLICLAZIDE	80MG	TABLET	Discontinued	2018-09-07	2018-09-15	60512
DIAMICRON	80MG	TABLET	Discontinued	2022-08-31	2022-10-03	168298
GLICLAZIDE-80	80MG	TABLET	Discontinued	2021-03-29	2021-03-30	136513
MYLAN-GLICLAZIDE	80MG	TABLET	Discontinued	2017-07-18	2017-12-02	16126
SANDOZ GLICLAZIDE MR	30MG	TABLET (EXTENDED-RELEASE)	Discontinued	2024-12-06	2024-12-07	245021
SANDOZ GLICLAZIDE MR	30MG	TABLET (EXTENDED-RELEASE)	Discontinued	2024-12-06	2024-12-07	245024
SANDOZ GLICLAZIDE MR	60MG	TABLET (EXTENDED-RELEASE)	Discontinued	2024-12-06	2024-12-07	245027
SANDOZ GLICLAZIDE MR	60MG	TABLET (EXTENDED-RELEASE)	Discontinued	2024-12-06	2024-12-07	245030

1

Showing 1 to 8 of 8